Published in Am J Obstet Gynecol on April 30, 2013
Progesterone to prevent spontaneous preterm birth. Semin Fetal Neonatal Med (2013) 1.00
Vaginal progesterone, but not 17α-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface. Am J Obstet Gynecol (2015) 0.79
Bridging progestogens in pregnancy and pregnancy prevention. Endocr Connect (2015) 0.77
17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study. Am J Obstet Gynecol (2017) 0.76
What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth. Semin Perinatol (2016) 0.75
Recent advances in the prevention of preterm birth. F1000Res (2017) 0.75
Recurrent pregnancy loss: current perspectives. Int J Womens Health (2017) 0.75
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med (2003) 9.57
Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med (2007) 5.36
Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol (2011) 4.31
Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol (2011) 2.95
A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med (2007) 2.73
Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial. Am J Obstet Gynecol (2013) 2.72
Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science (1989) 2.03
Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts. Semin Reprod Med (2007) 1.96
Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol (2012) 1.91
Progesterone for preterm birth prevention: an evolving intervention. Am J Obstet Gynecol (2009) 1.67
The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time. Am J Obstet Gynecol (2009) 1.66
Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial. Am J Obstet Gynecol (2010) 1.64
17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol (2012) 1.49
The Albert Lasker Medical Awards. RU-486 as an antiprogesterone steroid. From receptor to contragestion and beyond. JAMA (1989) 1.43
ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth. Obstet Gynecol (2008) 1.42
Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis. Ultrasound Obstet Gynecol (2012) 1.39
Control and assessment of the uterus and cervix during pregnancy and labour. Hum Reprod Update (1999) 1.39
Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice. Am J Pathol (2011) 1.25
Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol (2007) 1.24
Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation. Am J Obstet Gynecol (2011) 1.24
All progestins are not created equal. Steroids (2003) 1.23
The significance of the human corpus luteum in pregnancy maintenance. I. Preliminary studies. Am J Obstet Gynecol (1972) 1.23
Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation. Am J Obstet Gynecol (2012) 1.22
Regulation of hyaluronan expression during cervical ripening. Glycobiology (2004) 1.21
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev (2012) 1.20
Progesterone supplementation and the prevention of preterm birth. Rev Obstet Gynecol (2011) 1.11
Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol (2009) 1.06
Classification and pharmacology of progestins. Maturitas (2009) 1.06
Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins. Am J Obstet Gynecol (2007) 1.06
Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery. Diabetes Care (2007) 1.04
Estrogen and progesterone metabolism in the cervix during pregnancy and parturition. J Clin Endocrinol Metab (2008) 1.04
Labor induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study. Obstet Gynecol (1992) 1.04
Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society. Menopause (2003) 1.02
Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions. Am J Obstet Gynecol (2008) 1.02
The molecular mechanisms of cervical ripening differ between term and preterm birth. Endocrinology (2011) 1.01
Mifepristone-induced cervical ripening: structural, biomechanical, and molecular events. Am J Obstet Gynecol (2006) 1.00
The use of progesterone for prevention of preterm birth. J Obstet Gynaecol Can (2008) 0.97
Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro. Reprod Biol Endocrinol (2004) 0.97
Preventing cervical ripening: the primary mechanism by which progestational agents prevent preterm birth? Am J Obstet Gynecol (2008) 0.96
A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix. J Perinat Med (2013) 0.95
The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery. Hum Reprod (1994) 0.94
Peripheral plasma progesterone levels during human pregnancy and labor. Am J Obstet Gynecol (1971) 0.94
Termination of very early pregnancy by RU 486--an antiprogestational compound. Contraception (1984) 0.93
Hormonal regulation of matrix metalloproteinase 9/gelatinase B gene expression in rabbit uterine cervical fibroblasts. Biol Reprod (1997) 0.93
The effect of luteectomy-induced progesterone-withdrawal on the oxytocin and prostaglandin response of the first trimester pregnant human uterus. Prostaglandins (1973) 0.91
Progesterone withdrawal promotes remodeling processes in the nonpregnant mouse cervix. Biol Reprod (2009) 0.90
Cervical ripening in humans: potential roles of estrogen, progesterone, and insulin-like growth factor-I. Am J Obstet Gynecol (1996) 0.90
Collagen remodelling in the guinea-pig uterine cervix at term is associated with a decrease in progesterone receptor expression. Mol Hum Reprod (2003) 0.90
Suppression of interleukin 8 production by progesterone in rabbit uterine cervix. Biochem J (1994) 0.89
The effect of progesterone on myometrial contractility, potassium channels, and tocolytic efficacy. Reprod Sci (2009) 0.89
The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies. Am J Obstet Gynecol (2009) 0.89
Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy. Obstet Gynecol (2009) 0.89
Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle. Am J Obstet Gynecol (2010) 0.88
Ripening of the uterine cervix of the guinea-pig after treatment with the progesterone antagonist onapristone (ZK 98.299): an electron microscopic study. Hum Reprod (1989) 0.86
Mifepristone for labour induction after previous caesarean section. Br J Obstet Gynaecol (1994) 0.85
Remodeling of the cervix and parturition in mice lacking the progesterone receptor B isoform. Biol Reprod (2011) 0.84
[RU 486 (mifepristone): a new tool for labor induction women at term with live fetus]. Contracept Fertil Sex (Paris) (1992) 0.83
Antenatal progesterone to prevent preterm birth. Lancet (2009) 0.83
Evaluation of the use of Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy. Int J Gynaecol Obstet (1982) 0.83
Prevention of preterm birth by progestational agents: what are the molecular mechanisms? Am J Obstet Gynecol (2013) 0.83
The rebirth of progesterone in the prevention of preterm labor. Ann Pharmacother (2013) 0.82
Progesterone and preterm: seventy years of "déjà vu" or "still to be seen"? Birth (2004) 0.82
What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone? Obstet Gynecol Clin North Am (2011) 0.81
[The value of RU-486 (mifepristone) in medical indications of the induction of labor at term. Results of a double-blind randomized prospective study (RU-486 versus placebo)]. J Gynecol Obstet Biol Reprod (Paris) (1993) 0.80
Comparison of the mechanisms responsible for cervical remodeling in preterm and term labor. J Reprod Immunol (2013) 0.79
Forgotten "father of progesterone". Am J Obstet Gynecol (2009) 0.78
The critical control of progesterone levels and pregnancy by antiprogesterone. Am J Obstet Gynecol (1976) 0.77
Interruption of early pregnancy by an anti-progestational compound, RU 486. Eur J Obstet Gynecol Reprod Biol (1985) 0.76
Clinical application of nitric oxide donors and blockers. Hum Reprod (1998) 0.76
Was the preterm birth rate in the placebo group too high in the Meis MFMU Network trial of 17-OHPC? Am J Obstet Gynecol (2010) 0.76
Prematurity prevention: the role of progesterone. Curr Opin Obstet Gynecol (2009) 0.76
Prevention of the abortifacient action of antiprogesterone serum by progesterone. Am J Obstet Gynecol (1977) 0.76
Epidemiology and causes of preterm birth. Lancet (2008) 18.96
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06
A systems biology approach for pathway level analysis. Genome Res (2007) 6.95
Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21
A novel signaling pathway impact analysis. Bioinformatics (2008) 5.06
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med (2012) 3.43
Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One (2008) 3.01
Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet (2008) 2.90
Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol (2007) 2.78
Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol (2003) 2.65
Machine learning and its applications to biology. PLoS Comput Biol (2007) 2.57
Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol (2003) 2.55
Age-related testosterone depletion and the development of Alzheimer disease. JAMA (2004) 2.45
Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med (2008) 2.44
Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev (2002) 2.42
The fetal inflammatory response syndrome. Clin Obstet Gynecol (2007) 2.36
Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists. Fertil Steril (2004) 2.33
Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol (2002) 2.27
Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21
Listeriosis in human pregnancy: a systematic review. J Perinat Med (2011) 2.20
Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring) (2006) 2.17
Progesterone receptors: form and function in brain. Front Neuroendocrinol (2008) 2.15
Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res (2004) 2.14
The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified? Am J Obstet Gynecol (2006) 2.11
Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol (2010) 2.00
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci (2007) 2.00
The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol (2010) 1.99
Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med (2005) 1.99
Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception (2010) 1.96
Evolution of the mammalian placenta revealed by phylogenetic analysis. Proc Natl Acad Sci U S A (2006) 1.89
Genomics, biogeography, and the diversification of placental mammals. Proc Natl Acad Sci U S A (2007) 1.86
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med (2009) 1.84
A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med (2006) 1.82
Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore. Int J Cancer (2012) 1.82
Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol (2004) 1.81
Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol (2010) 1.77
Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. Am J Obstet Gynecol (2009) 1.77
Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab (2006) 1.76
Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol (2010) 1.74
Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature. Am J Obstet Gynecol (2006) 1.73
Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.69
Gene-centric genomewide association study via entropy. Genetics (2008) 1.68
Effectiveness of levonorgestrel emergency contraception given before or after ovulation--a pilot study. Contraception (2006) 1.68
Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab (2007) 1.66
Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol (2012) 1.66
Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.65
Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol (2004) 1.64
A short cervix in women with preterm labor and intact membranes: a risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol (2005) 1.64
Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis (2008) 1.63
Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med (2007) 1.62
Insulin resistance and prostate cancer risk. J Natl Cancer Inst (2003) 1.61
The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med (2008) 1.60
Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol (2004) 1.60
Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2013) 1.58
Intrauterine endotoxin administration leads to white matter diffusivity changes in newborn rabbits. J Child Neurol (2009) 1.58
Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol (2002) 1.58
Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol (2011) 1.56
Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev (2006) 1.56
Structural and functional comparison of mast cells in the pregnant versus nonpregnant human uterus. Am J Obstet Gynecol (2006) 1.54
The clinical significance of a positive Amnisure test in women with term labor with intact membranes. J Matern Fetal Neonatal Med (2009) 1.54
Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol Biomarkers Prev (2007) 1.53
A systematic approach to the use of the multiplanar display in evaluation of abnormal vascular connections to the fetal heart using 4-dimensional ultrasonography. J Ultrasound Med (2007) 1.53
Analysis of microarray experiments of gene expression profiling. Am J Obstet Gynecol (2006) 1.53
Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception (2009) 1.52
Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol (2004) 1.51
Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol (2009) 1.50
The evolution of menstruation: a new model for genetic assimilation: explaining molecular origins of maternal responses to fetal invasiveness. Bioessays (2011) 1.50
The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med (2008) 1.50
Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol (2004) 1.49
The prognosis of pregnancy conceived despite the presence of an intrauterine device (IUD). J Perinat Med (2010) 1.48
Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol (2007) 1.47
Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women. J Clin Endocrinol Metab (2010) 1.46
Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy. Menopause (2014) 1.46
Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol Cell Biol (2006) 1.46
The risk of impending preterm delivery in asymptomatic patients with a nonmeasurable cervical length in the second trimester. Am J Obstet Gynecol (2010) 1.45
Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome. Fertil Steril (2012) 1.45
A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem (2001) 1.42
A comparison of gene set analysis methods in terms of sensitivity, prioritization and specificity. PLoS One (2013) 1.41
Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes. Hum Hered (2006) 1.41
Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. Prostate (2003) 1.40
Reliability of extraction/chromatography RIAs. Clin Chem (2004) 1.40
Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature Challenge. Bioinformatics (2013) 1.39
Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol (2010) 1.39
The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol (2003) 1.38
Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab (2007) 1.38
TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol (2009) 1.37
The transcriptome of the fetal inflammatory response syndrome. Am J Reprod Immunol (2010) 1.37
Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy. Am J Obstet Gynecol (2008) 1.36
Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.35
Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet (2004) 1.35
Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins. Contraception (2008) 1.34
Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol (2008) 1.34
N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury. Ann Neurol (2007) 1.33
Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2004) 1.30
Varying coefficient model for gene-environment interaction: a non-linear look. Bioinformatics (2011) 1.29
Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.29
Activation of TLR3 in the trophoblast is associated with preterm delivery. Am J Reprod Immunol (2009) 1.29
The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol (2010) 1.29
A functional SNP in the promoter of the SERPINH1 gene increases risk of preterm premature rupture of membranes in African Americans. Proc Natl Acad Sci U S A (2006) 1.27
A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol (2005) 1.27